| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/2006 | CN1723480A System and method for transparent early detection, warning, and intervention during a medical procedure |
| 01/18/2006 | CN1723215A Anhydrous crystalline azido cytosine hemisulfate derivative |
| 01/18/2006 | CN1723214A Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 01/18/2006 | CN1723212A Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 01/18/2006 | CN1723211A Therapeutic agent for schizophrenia |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723209A Indol derivatives and their use as 5-HT ligands |
| 01/18/2006 | CN1723208A Magnesium salt of imidazole derivative |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723206A High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 01/18/2006 | CN1723205A Substituted benzoxazinones and uses thereof |
| 01/18/2006 | CN1723204A Benzoxazole derivatives and their use as adenosine receptor ligands |
| 01/18/2006 | CN1723201A Blood-brain barrier disruption inhibitors |
| 01/18/2006 | CN1723200A (2-carboxamido) (3-amino) thiophene compounds |
| 01/18/2006 | CN1723199A 1,4-disubstituted piperidine derivatives and their use as 11-beta hsd1 inhibitors |
| 01/18/2006 | CN1723198A Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/18/2006 | CN1723197A Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723192A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 01/18/2006 | CN1723190A Polymorphic forms of nateglinide |
| 01/18/2006 | CN1723059A Insulin receptor activators for the treatment of human body metabolic disorder resulting from treatment of HIV infection with HIV protease inhibitors |
| 01/18/2006 | CN1723052A Enhanced parmacokinetic profile of hydrophobic dopamine agonists administered to the dermis |
| 01/18/2006 | CN1723037A Methods and compositions for promoting the maturation of monocytes |
| 01/18/2006 | CN1723035A Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 01/18/2006 | CN1723034A Composition and method for treating diabetes |
| 01/18/2006 | CN1723028A Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same |
| 01/18/2006 | CN1723027A Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/18/2006 | CN1723026A Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia |
| 01/18/2006 | CN1723025A Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV |
| 01/18/2006 | CN1723024A Method for the treatment of bone disorders |
| 01/18/2006 | CN1723023A morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction |
| 01/18/2006 | CN1723022A inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 01/18/2006 | CN1723021A Stable solid medicinal composition for oral administration. |
| 01/18/2006 | CN1723020A Indole derivatives as beta-2 agonists |
| 01/18/2006 | CN1723019A Compounds having anti-proliferative properties |
| 01/18/2006 | CN1723018A Microtubule stabilisers for treating stenosis in stents |
| 01/18/2006 | CN1723017A Methods and compositions to treat conditions associated with neovascularization |
| 01/18/2006 | CN1723016A Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 01/18/2006 | CN1723015A Fatigue reducing agent |
| 01/18/2006 | CN1723014A Agent for dissolving dental calculi and dental caries |
| 01/18/2006 | CN1723013A Use of estrogen receptor alpha modulators for the treatment of multiple sclerosis |
| 01/18/2006 | CN1723012A Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 01/18/2006 | CN1723011A Breath freshening and oral cleansing product with magnolia bark extract |
| 01/18/2006 | CN1722956A Oral veterinary drug delivery system and/or feed additive delivery system, process for the preparation and use thereof |
| 01/18/2006 | CN1721807A Reutilization method and apparatus for activatory furnace exhaust gas |
| 01/18/2006 | CN1721553A Methods for assessing and treating cancer |
| 01/18/2006 | CN1721525A Method for inducing neural differentiation and composition |
| 01/18/2006 | CN1721456A Novel ethylenic copolymers, compositions and methods of the same |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721428A Compound and method for treating cancer |
| 01/18/2006 | CN1721427A Novel erythromycin derivatives |
| 01/18/2006 | CN1721426A Anthraquinone glycoside compounds containing glucopyranoside group and use thereof |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721416A Substituted methylene pyrones derivatives and their preparing process and use |
| 01/18/2006 | CN1721413A Barbituric acids and their preparation process and use |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1721409A Dibenzo(b,f)azepine derivatives |
| 01/18/2006 | CN1721408A 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof |
| 01/18/2006 | CN1721403A Water soluble bilirubin and its synthesis process and use |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/18/2006 | CN1721004A Biological active antibiotic dressing |
| 01/18/2006 | CN1720999A Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof |
| 01/18/2006 | CN1720995A The treatment of respiratory diseases |
| 01/18/2006 | CN1720971A Stomatocace powder |
| 01/18/2006 | CN1720945A Medicine for treating calculus in urinary system |
| 01/18/2006 | CN1720930A Anti-AIDS material drug, tablet, capsule, oral liquid and preparation method thereof |
| 01/18/2006 | CN1720928A Bone-setting pain-stopping plaster |
| 01/18/2006 | CN1720923A Medicine for treating cerebrovascular diseases |
| 01/18/2006 | CN1720922A Preparation of anti-infection CpG oligonucleotide DNA preparation and its application technology |
| 01/18/2006 | CN1720921A Antineoplastic medicinal composition, its preparation method and application |
| 01/18/2006 | CN1720920A Sodium aescinate soft capsule and method for preparing the same |
| 01/18/2006 | CN1720919A Mesalazine controlled release oral pharmaceutical compositions |
| 01/18/2006 | CN1720918A Compound capsule with dextromethorphan and promethazine and method for preparing the same |
| 01/18/2006 | CN1720917A Cough treating orally disintegrating tablet |
| 01/18/2006 | CN1720916A Rapidly decomposing administrable form for releasing active ingredient in oral cavity or bodily cavity |
| 01/18/2006 | CN1720915A Anti-beta-lactamase antibiotic composite preparation |
| 01/18/2006 | CN1720914A Anti-beta-lactamase antibiotic composite preparation |
| 01/18/2006 | CN1720913A Water-soluble triazole fungicide |
| 01/18/2006 | CN1720912A Pharmaceutical compositions |
| 01/18/2006 | CN1720911A Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof |
| 01/18/2006 | CN1720910A Application of Cytospora bacterin B in preparation of antineoplastic medicine |
| 01/18/2006 | CN1720909A Application of Cytospora bacterin B in preparation of antifundal medicine |
| 01/18/2006 | CN1720908A Beta-Asarone transdermal plaster |
| 01/18/2006 | CN1720907A Apoplexy treating injection |
| 01/18/2006 | CN1720906A Asthma treating spray |
| 01/18/2006 | CN1720905A Application of beta-Asarone in pharmacy |
| 01/18/2006 | CN1720904A Hemodilution facilitated by monitoring oxygenation status |
| 01/18/2006 | CN1720876A Uterus neck skin tissue engineering scaffold and method for producing the same |
| 01/18/2006 | CN1237185C SARS coronavirus 3Cl protease two-dimensional model and medicine preventing SARS |
| 01/18/2006 | CN1237176C Method for remodelling cell wall polysaccharide structures in plants |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/18/2006 | CN1237070C Biomolecule with therapeutic tumour action and its use |
| 01/18/2006 | CN1237065C Composition of norcantharidin with anticancer drugs containing platinum and its usage |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1237056C Oxazolidone compound, preparing method and use thereof |